Ecstasy-for-Medicine Advocate Raises $100 Million
Updated Jan. 5, 2024 8:54 am ETThe Multidisciplinary Association for Psychedelic Studies, a nonprofit leader in the pharmaceutical psychedelics industry, ...
Updated Jan. 5, 2024 8:54 am ETThe Multidisciplinary Association for Psychedelic Studies, a nonprofit leader in the pharmaceutical psychedelics industry, ...
It usually takes time for scientific discoveries in the lab to make their way to the market.The groundbreaking gene-editing technology ...
The potential FDA approval of BioMarin’s gene therapy for hemophilia A would be a major win, but patient uptake could ...
Developers of Alzheimer’s drugs have work cut out for them getting the treatments to patients.
ShareListen(2 min)
MarketsFinancial RegulationProsecutors and regulators say healthcare company executive tipped friend to company’s drug approval
Like many patients suffering from amyotrophic lateral sclerosis, or ALS—also known as Lou Gehrig’s disease—Layne Oliff didn’t have any time ...